Filing Details
- Accession Number:
- 0000899243-21-034143
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-25 16:15:51
- Reporting Period:
- 2021-08-23
- Accepted Time:
- 2021-08-25 16:15:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1682069 | Mr. P. William Burke | 125 Summer Street Boston MA 02110 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-23 | 11,232 | $34.21 | 41,523 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-08-23 | 11,435 | $41.64 | 52,958 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-08-23 | 22,667 | $60.51 | 30,291 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-08-23 | 11,232 | $0.00 | 11,232 | $34.21 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-08-23 | 11,435 | $0.00 | 11,435 | $41.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-10-25 | 2023-10-25 | No | 4 | M | Direct |
0 | 2021-06-06 | 2024-06-06 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan.
- Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- This number includes unvested RSUs previously reported.